BANK VONTOBEL/PUT/NOVARTIS N/85/0.1/20.06.25 Share Price

Warrant

DE000VD49RT6

Market Closed - Boerse Frankfurt Warrants 18:55:09 28/06/2024 BST
0.29 EUR -6.45% Intraday chart for BANK VONTOBEL/PUT/NOVARTIS N/85/0.1/20.06.25
Current month-23.68%
1 month-34.09%
Date Price Change
28/06/24 0.29 -6.45%
27/06/24 0.31 +3.33%
26/06/24 0.3 0.00%
25/06/24 0.3 0.00%
24/06/24 0.3 -14.29%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 06:55 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
WKN VD49RT
ISINDE000VD49RT6
Date issued 30/04/2024
Strike 85 CHF
Maturity 20/06/2025 (356 Days)
Parity 10 : 1
Emission price 0.56
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.58
Lowest since issue 0.28
Delta-0.25x
Omega 8.128
Premium14.67x
Gearing32.75x
Moneyness 0.8839
Difference Strike -11.17 CHF
Difference Strike %-13.14%
Spread 0.03
Spread %9.38%
Theoretical value 0.3050
Implied Volatility 18.77 %
Total Loss Probability 68.00 %
Intrinsic value 0.000000
Present value 0.3050
Break even 82.06 €
Theta-0.01x
Vega0.03x
Rho-0.03x

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107 USD
Average target price
110.3 USD
Spread / Average Target
+3.04%
Consensus